Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission

R Giacomelli, R Caporali, F Ciccia… - Autoimmunity …, 2023 - Elsevier
We performed a comprehensive systematic targeted literature review and used the Delphi
method to formulate expert consensus statements to guide the treatment of adult-onset Still's …

[HTML][HTML] Care pathway analysis and evidence gaps in adult-onset Still's disease: interviews with experts from the UK, France, Italy, and Germany

F Ursini, E Gregg, V Canon-Garcia, H Rabijns… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Methods Semi-structured interviews and thematic analysis were conducted. Eleven
clinicians were interviewed between May and July 2022: four were based in Italy, three in …

[HTML][HTML] From Pathogenesis to Treatment—New Perspectives in Rheumatology

E Rezus, C Codreanu - International Journal of Molecular Sciences, 2023 - mdpi.com
Rheumatic diseases are characterized by complex pathogenic mechanisms, with intricate
signaling pathways and various imbalances of proinflammatory and anti-inflammatory …

[HTML][HTML] Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease

D Zhu, L Chen, J Meng, M Wang, Y Ma, X Chen… - Journal of …, 2024 - Elsevier
Macrophage activation syndrome (MAS) is a potentially fatal consequence of adult-onset
Still's disease (AOSD), driven by a cytokine storm. Efficient early diagnosis of AOSD …

Unveiling the Mystery of Adult-Onset Still's Disease: A Compelling Case Report

D Sola, C Smirne, F Bruggi, C Bottino Sbaratta… - Life, 2024 - mdpi.com
Adult-onset Still's disease (AOSD) is a rare systemic inflammatory disorder. Diagnosis can
take a long time, especially in the presence of confounding factors, and it is, to some extent …

Successful Treatment of Recurrent Adult-Onset Still's Disease with Tocilizumab: A Case Report and Literature Review

X Zhong, T Xu, T Li, N Luo, N Luo… - Clinical, Cosmetic and …, 2023 - Taylor & Francis
Adult-onset Still's disease (AOSD) is considered a rare autoimmune inflammatory disorder
with an unclear etiology and pathogenesis. The main clinical manifestations of this disease …

Clinicopathologic Features of Adult-onset Still's Disease Complicated by Severe Liver Injury

M Kurokawa, T Hioki, T Aoyagi, M Takahashi… - Internal …, 2024 - jstage.jst.go.jp
Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder. Severe liver injury
has rarely been reported, although liver enzyme elevation is a common complication of …

[HTML][HTML] Atypical cutaneous presentation of AOSD with persistent itchy urticaria: A case report

J Lou, X Zhang - Medicine, 2023 - journals.lww.com
Interventions: Initially, the patient was administered an intravenous infusion of
methylprednisolone at 40 mg once daily. This was later transitioned to oral administration …

[HTML][HTML] A Novel Therapy for a Rare Condition: Continuous Anakinra Infusion for a Patient With Macrophage Activation Syndrome

M Gullickson, L Nichols, M Scheibe - Cureus, 2023 - ncbi.nlm.nih.gov
Macrophage activation syndrome (MAS) is a type of hemophagocytic lymphohistiocytosis
(HLH), which occurs due to excessive stimulation of the immune system. Common …

[PDF][PDF] Adult-Onset Still's Disease (AOSD) Associated With Collagenous Colitis (CC) and Basedow's Disease: A Case Report

A Stiuliuc, A Kapuczinski, M Weynand, C Lemoine… - Cureus, 2023 - cureus.com
Adult-onset Still's disease (AOSD) is a rare auto-inflammatory syndrome of unknown
etiology. Basedow's disease is a common cause of auto-immune hyperthyroidism …